title: Letter by Karasawa and Takahashi Regarding Article, "Anti-inflammatory and Antiatherogenic Effects of the Inflammasome NLRP3 Inhibitor Arglabin in ApoE2.Ki Mice Fed a High-Fat Diet".
authors.affiliation: Division of Inflammation Research, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan.
authors.forename: Tadayoshi
authors.initials: T
authors.lastname: Karasawa
authors.affiliation: Division of Inflammation Research, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan.
authors.forename: Masafumi
authors.initials: M
authors.lastname: Takahashi
mesh_terms: D000818:Animals; D053329:Apolipoprotein E2 / Q000172:deficiency*; D050197:Atherosclerosis / Q000188:drug therapy*; D002352:Carrier Proteins / Q000037:antagonists & inhibitors*; D059305:Diet, High-Fat / Q000009:adverse effects*; D005260:Female; D058847:Inflammasomes / Q000037:antagonists & inhibitors*; D012717:Sesquiterpenes / Q000627:therapeutic use*
chemical_list: D053329:Apolipoprotein E2; D002352:Carrier Proteins; D058847:Inflammasomes; D012717:Sesquiterpenes